vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.
Cronos Group Inc. is the larger business by last-quarter revenue ($44.5M vs $22.7M, roughly 2.0× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -4.1%, a 4.8% gap on every dollar of revenue. On growth, Cronos Group Inc. posted the faster year-over-year revenue change (47.0% vs 22.9%). Cronos Group Inc. produced more free cash flow last quarter ($9.7M vs $2.0M). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs 29.8%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
CRON vs RFIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $22.7M |
| Net Profit | $-1.8M | $173.0K |
| Gross Margin | 36.4% | 36.8% |
| Operating Margin | -16.8% | 4.0% |
| Net Margin | -4.1% | 0.8% |
| Revenue YoY | 47.0% | 22.9% |
| Net Profit YoY | -104.2% | 172.7% |
| EPS (diluted) | $-0.01 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.5M | $22.7M | ||
| Q3 25 | $36.3M | $19.8M | ||
| Q2 25 | $33.5M | $18.9M | ||
| Q1 25 | $32.3M | $19.2M | ||
| Q4 24 | $30.3M | $18.5M | ||
| Q3 24 | $34.3M | $16.8M | ||
| Q2 24 | $27.8M | $16.1M | ||
| Q1 24 | $25.3M | $13.5M |
| Q4 25 | $-1.8M | $173.0K | ||
| Q3 25 | $26.0M | $392.0K | ||
| Q2 25 | $-39.7M | $-245.0K | ||
| Q1 25 | $6.1M | $-245.0K | ||
| Q4 24 | $43.7M | $-238.0K | ||
| Q3 24 | $8.3M | $-705.0K | ||
| Q2 24 | $-8.8M | $-4.3M | ||
| Q1 24 | $-2.2M | $-1.4M |
| Q4 25 | 36.4% | 36.8% | ||
| Q3 25 | 50.4% | 34.0% | ||
| Q2 25 | 43.4% | 31.5% | ||
| Q1 25 | 42.6% | 29.8% | ||
| Q4 24 | 35.7% | 31.3% | ||
| Q3 24 | 10.5% | 29.5% | ||
| Q2 24 | 22.7% | 29.9% | ||
| Q1 24 | 17.7% | 24.5% |
| Q4 25 | -16.8% | 4.0% | ||
| Q3 25 | -1.4% | 3.6% | ||
| Q2 25 | -15.9% | 0.6% | ||
| Q1 25 | -12.6% | 0.3% | ||
| Q4 24 | -37.5% | 0.5% | ||
| Q3 24 | -98.2% | -2.5% | ||
| Q2 24 | -56.1% | -2.6% | ||
| Q1 24 | -63.1% | -15.5% |
| Q4 25 | -4.1% | 0.8% | ||
| Q3 25 | 71.4% | 2.0% | ||
| Q2 25 | -118.7% | -1.3% | ||
| Q1 25 | 19.0% | -1.3% | ||
| Q4 24 | 144.3% | -1.3% | ||
| Q3 24 | 24.4% | -4.2% | ||
| Q2 24 | -31.5% | -26.7% | ||
| Q1 24 | -8.9% | -10.1% |
| Q4 25 | $-0.01 | $0.01 | ||
| Q3 25 | $0.07 | $0.04 | ||
| Q2 25 | $-0.10 | $-0.02 | ||
| Q1 25 | $0.02 | $-0.02 | ||
| Q4 24 | $0.12 | $-0.02 | ||
| Q3 24 | $0.02 | $-0.07 | ||
| Q2 24 | $-0.02 | $-0.41 | ||
| Q1 24 | $-0.01 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $35.2M |
| Total Assets | $1.2B | $73.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $831.8M | $5.1M | ||
| Q3 25 | $824.2M | $3.0M | ||
| Q2 25 | $834.4M | $3.6M | ||
| Q1 25 | $837.8M | $1.3M | ||
| Q4 24 | $858.8M | $839.0K | ||
| Q3 24 | $862.0M | $1.8M | ||
| Q2 24 | $848.2M | $1.4M | ||
| Q1 24 | $855.1M | $4.5M |
| Q4 25 | $1.1B | $35.2M | ||
| Q3 25 | $1.1B | $34.8M | ||
| Q2 25 | $1.1B | $34.2M | ||
| Q1 25 | $1.1B | $34.2M | ||
| Q4 24 | $1.1B | $34.1M | ||
| Q3 24 | $1.1B | $34.1M | ||
| Q2 24 | $1.1B | $34.6M | ||
| Q1 24 | $1.1B | $38.7M |
| Q4 25 | $1.2B | $73.0M | ||
| Q3 25 | $1.2B | $73.2M | ||
| Q2 25 | $1.2B | $72.7M | ||
| Q1 25 | $1.2B | $70.4M | ||
| Q4 24 | $1.2B | $71.0M | ||
| Q3 24 | $1.2B | $71.9M | ||
| Q2 24 | $1.1B | $72.8M | ||
| Q1 24 | $1.1B | $79.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $2.1M |
| Free Cash FlowOCF − Capex | $9.7M | $2.0M |
| FCF MarginFCF / Revenue | 21.8% | 9.0% |
| Capex IntensityCapex / Revenue | 4.8% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 12.13× |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $2.1M | ||
| Q3 25 | $13.3M | $-311.0K | ||
| Q2 25 | $2.8M | $2.2M | ||
| Q1 25 | $-2.1M | $601.0K | ||
| Q4 24 | $7.7M | $-244.0K | ||
| Q3 24 | $11.6M | $2.4M | ||
| Q2 24 | $1.7M | $197.0K | ||
| Q1 24 | $-2.2M | $840.0K |
| Q4 25 | $9.7M | $2.0M | ||
| Q3 25 | $8.8M | $-419.0K | ||
| Q2 25 | $-1.0M | $2.2M | ||
| Q1 25 | $-17.4M | $574.0K | ||
| Q4 24 | $4.2M | $-418.0K | ||
| Q3 24 | $5.2M | $2.1M | ||
| Q2 24 | $1.0M | $28.0K | ||
| Q1 24 | $-3.9M | $697.0K |
| Q4 25 | 21.8% | 9.0% | ||
| Q3 25 | 24.3% | -2.1% | ||
| Q2 25 | -3.0% | 11.4% | ||
| Q1 25 | -53.8% | 3.0% | ||
| Q4 24 | 13.8% | -2.3% | ||
| Q3 24 | 15.1% | 12.6% | ||
| Q2 24 | 3.7% | 0.2% | ||
| Q1 24 | -15.5% | 5.2% |
| Q4 25 | 4.8% | 0.3% | ||
| Q3 25 | 12.3% | 0.5% | ||
| Q2 25 | 11.5% | 0.2% | ||
| Q1 25 | 47.3% | 0.1% | ||
| Q4 24 | 11.7% | 0.9% | ||
| Q3 24 | 18.7% | 1.5% | ||
| Q2 24 | 2.6% | 1.0% | ||
| Q1 24 | 6.8% | 1.1% |
| Q4 25 | — | 12.13× | ||
| Q3 25 | 0.51× | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
